The Journal of Urology
Volume 178, Issue 4 , Pages 1150-1156 , October 2007

Application of Artificial Intelligence to the Management of Urological Cancer

  • Maysam F. Abbod

      Affiliations

    • School of Engineering and Design, Brunel University, West London, United Kingdom
    • Equal study contribution.
    • ,
  • James W.F. Catto

      Affiliations

    • Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
    • Equal study contribution.
    • ,
  • Derek A. Linkens

      Affiliations

    • Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, United Kingdom
    • ,
  • Freddie C. Hamdy

      Affiliations

    • Academic Urology Unit, University of Sheffield, Sheffield, United Kingdom
    • Corresponding Author InformationCorrespondence: Academic Urology Unit, K Floor, Royal Hallamshire Hospital, Glossop Rd., Sheffield, S10 2JF, United Kingdom (telephone: +44 +114 271 2154; FAX: +44 +114 271 2268).

Received 13 October 2006

References 

  1. Schwarzer G, Schumacher M. Artificial neural networks for diagnosis and prognosis in prostate cancer. Semin Urol Oncol. 2002;20:89
  2. Sargent DJ. Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer. 2001;91:1636
  3. Schwarzer G, Vach W, Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med. 2000;19:541
  4. Winkler RL. An Introduction to Bayesian Inference and Decision. Toronto: Holt and, Rinehart and Winston; 1972;
  5. Onisko A, Druzdzel MJ, Wasyluk H. A Bayesian network model for diagnosis of liver disorders. In: Presented at Eleventh Conference on Biocybernetics and Biomedical Engineering, Warsaw, Poland, December 2–4. 1999;
  6. Jackson P. Forthcoming. In: Introduction to Expert Systems. 3rd ed.. London: Longman Addison Wesley; 1986;
  7. Anagnostou T, Remzi M, Lykourinas M, Djavan B. Artificial neural networks for decision-making in urologic oncology. Eur Urol. 2003;43:596
  8. Catto JWF, Linkens DA, Abbod MF, Chen M, Burton JL, Feeley KM, et al. Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks. Clin Cancer Res. 2003;9:4172
  9. Chen M, Linkens DA. A systematic neurofuzzy modelling framework with application to material property prediction. IEEE Trans Syst Man Cybern B. 2001;31:781
  10. Catto JWF, Abbod MF, Linkens DA, Hamdy FC. Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression. J Urol. 2006;175:474
  11. Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol. 2002;20:921
  12. Tewari A, Narayan P. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks. J Urol. 1998;160:430
  13. Tewari A, Issa M, El-Galley R, Stricker H, Peabody J, Pow-Sang J, et al. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. Mol Urol. 2001;5:163
  14. Babaian RJ, Fritsche H, Ayala A, Bhadkamkar V, Johnston DA, Naccarato W, et al. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL. Urology. 2000;56:1000
  15. Naguib RN, Robinson MC, Neal DE, Hamdy FC. Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study. Br J Cancer. 1998;78:246
  16. Khan J, Wei JS, Ringner M, Saal LH, Ladanyi M, Westermann F, et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat Med. 2001;7:673
  17. Remzi M, Anagnostou T, Ravery V, Zlotta A, Stephan C, Marberger M, et al. An artificial neural network to predict the outcome of repeat prostate biopsies. Urology. 2003;62:456
  18. Babaian RJ, Fritsche HA, Zhang Z, Zhang KH, Madyastha KR, Barnhill SD. Evaluation of ProstAsure index in the detection of prostate cancer: a preliminary report. Urology. 1998;51:132
  19. Saritas I, Allahverdi N, Sert IUP. A fuzzy expert system design for diagnosis of prostate cancer. In: Presented at International Conference on Computer Systems and Technologies (e-Learning), Bulgaria, June 19–20. 2003;
  20. Montironi R, Bartels PH, Thompson D, Scarpelli M, Hamilton PW. Prostatic intraepithelial neoplasia (PIN) (Performance of Bayesian belief network for diagnosis and grading). J Pathol. 1995;177:153
  21. Batuello JT, Gamito EJ, Crawford ED, Han M, Partin AW, McLeod DG, et al. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. Urology. 2001;57:481
  22. Han M, Snow PB, Brandt JM, Partin AW. Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma. Cancer. 2001;91:1661
  23. Horner JK. A Bayesian-network sensitivity analysis of the Partin-table prostate cancer diagnostic protocol to single-bin promotion of Gleason Score. In: Presented at International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences, Las Vegas, Nevada, June 23–26. 2003;
  24. Mattfeldt T, Gottfried H, Wolter H, Schmidt V, Kestler HA, Mayer J. Classification of prostatic carcinoma with artificial neural networks using comparative genomic hybridization and quantitative stereological data. Pathol Res Pract. 2003;199:773
  25. Jung JK, Young HK, Yonggwan W. Proteomic pattern classification using bio-markers for prostate cancer diagnosis. In: Presented at Computational and Information Science: First International Symposium, Shanghai, People’s Republic of China, December 16–18. 2004;
  26. Kattan MW. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol, part 2. 2003;170:S6
  27. Gulliford SL, Webb S, Rowbottom CG, Corne DW, Dearnaley DP. Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. Radiother Oncol. 2004;71:3
  28. Han M, Snow PB, Epstein JI, Chan TY, Jones KA, Walsh PC, et al. A neural network predicts progression for men with Gleason score 3+4 versus 4+3 tumors after radical prostatectomy. Urology. 2000;56:994
  29. Poulakis V, Witzsch U, de Vries R, Emmerlich V, Meves M, Altmannsberger HM, et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. Urology. 2004;64:1165
  30. Mazzucchelli R, Santinelli A, Colanzi P, Streccioni M, Lopez-Beltran A, Scarpelli M, et al. Urothelial papillary lesions (Development of a Bayesian belief network for diagnosis and grading). Anticancer Res. 2001;21:1157
  31. Belacel N, Boulassel MR. Multicriteria fuzzy assignment method: a useful tool to assist medical diagnosis. Artif Intell Med. 2001;21:201
  32. Spyridonos P, Cavouras D, Ravazoula P, Nikiforidis G. Neural network-based segmentation and classification system for automated grading of histologic sections of bladder carcinoma. Anal Quant Cytol Histol. 2002;24:317
  33. Tasoulis DK, Spyridonos P, Pavlidis NG, Cavouras D, Ravazoula P, Nikiforidis G, et al. Urinary bladder tumor grade diagnosis using on-line trained neural networks. In: Presented at Seventh International Conference of Knowledge Based Intelligent Information and Engineering Systems, Oxford, United Kingdom, September 3–5. 2003;
  34. Pantazopoulos D, Karakitsos P, Iokim-Liossi A, Pouliakis A, Botsoli-Stergiou E, Dimopoulos C. Back propagation neural network in the discrimination of benign from malignant lower urinary tract lesions. J Urol. 1998;159:1619
  35. Parekattil SJ, Fisher HA, Kogan BA. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. J Urol. 2003;169:917
  36. Ji W, Naguib RN, Ghoneim MA. Neural network-based assessment of prognostic markers and outcome prediction in bilharziasis-associated bladder cancer. IEEE Trans Inf Technol Biomed. 2003;7:218
  37. Qureshi KN, Naguib RN, Hamdy FC, Neal DE, Mellon JK. Neural network analysis of clinicopathological and molecular markers in bladder cancer. J Urol. 2000;163:630
  38. Moul JW, Snow PB, Fernandez EB, Maher PD, Sesterhenn IA. Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer. J Urol. 1995;153:1674
  39. Feleppa EJ, Ennis RD, Schiff PB, Wuu CS, Kalisz A, Ketterling J, et al. Ultrasonic spectrum-analysis and neural-network classification as a basis for ultrasonic imaging to target brachytherapy of prostate cancer. Brachytherapy. 2002;1:48
  40. Maclin PS, Dempsey J, Brooks J, Rand J. Using neural networks to diagnose cancer. J Med Syst. 1991;15:11
  41. Prater JS, Richard WD. Segmenting ultrasound images of the prostate using neural networks. Ultrason Imaging. 1992;14:159
  42. Scheipers U, Ermert H, Sommerfeld HJ, Garcia-Schurmann M, Senge T, Philippou S. Ultrasonic multifeature tissue characterization for prostate diagnostics. Ultrasound Med Biol. 2003;29:1137
  43. Feleppa EJ, Porter CR, Ketterling J, Lee P, Dasgupta S, Urban S, et al. Recent developments in tissue-type imaging (TTI) for planning and monitoring treatment of prostate cancer. Ultrason Imaging. 2004;26:163
  44. Porter CR, Crawford ED. Combining artificial neural networks and transrectal ultrasound in the diagnosis of prostate cancer. Oncology (Williston Park). 2003;17:1395
  45. Huynen AL, Giesen RJ, de la Rosette JJ, Aarnink RG, Debruyne FM, Wijkstra H. Analysis of ultrasonographic prostate images for the detection of prostatic carcinoma: the automated urologic diagnostic expert system. Ultrasound Med Biol. 1994;20:1
  46. Nanayakkara ND, Samarabandu JK. Automatic prostate boundary detection in ultrasound images using multiresolution deformable models and fuzzy logic. In: Presented at Fourth International Conference of SPIE, International Society for Optical Engineering, Kiev, Ukraine, June 26–28. 2003;
  47. Scheipers U, Ermert H, Sommerfeld HJ, Garcia-Schurmann M, Kuhne K, Senge T, et al. Ultrasonic tissue characterization for prostate diagnostics: spectral parameters vs. texture parameters. Biomed Tech (Berl). 2003;48:122
  48. Lorenz A, Pesavento A, Scheipers U, Ermert H, Garcia Schurmann M, Sommerfeld HJ, et al. Ultrasonic tissue characterization assessment of prostate tissue malignancy in vivo using a conventional classifier based tissue classification approach and elastographic imaging. In: Presented at IEEE Ultrasonics Symposium, San Juan, Puerto Rico, October 22–25. 2000;
  49. Wells DM, Niederer J. A medical expert system approach using artificial neural networks for standardized treatment planning. Int J Radiat Oncol Biol Phys. 1998;41:173
  50. Meyer J, Phillips MH, Cho PS, Kalet I, Doctor JN. Application of influence diagrams to prostate intensity-modulated radiation therapy plan selection. Phys Med Biol. 2004;49:1637

 Supported by a Medical Research Council fellowship, a British Urological Foundation/Merck Sharpe and Dohme scholarship, and a GlaxoSmithKline Clinician Scientist award (JWFC).

PII: S0022-5347(07)01393-6

doi: 10.1016/j.juro.2007.05.122

The Journal of Urology
Volume 178, Issue 4 , Pages 1150-1156 , October 2007

Article Tools

* Image Usage & Resolution